Medical/Pharmaceuticals

InfiRay® Debuts at WIN EURASIA 2023

YANTAI, China, June 7, 2023 /PRNewswire/ -- IRay Technology Co., Ltd. (referred to as "InfiRay ®" below), a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul. InfiRay ® presented ...

2023-06-07 14:00 2189

Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix an nounced the release of clinical research results comparing the accuracy of its breast cancer prognostic test, GenesWellBCT, with OncotypeDX, the globally top-s...

2023-06-07 12:29 2784

BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia

* BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes inSoutheast Asia. * Cytiva's BioChallenge aims to support the innovation of biotech startups. Singapore, June 7, 2023 /PRNewswire/ -- Cytiva recognizes the talent, resource and scal...

2023-06-07 12:00 2759

First Medical Product in New Hybrid Light-Curable Adhesive Platform from Dymax

Offers Rapid Curing in Light or Darkness to a Wider Range of Substrates SINGAPORE, June 7, 2023 /PRNewswire/ -- Dymax, a leading manufacturer of rapid curing materials and equipment, is excited to announce the release of HLC-M-1000, the first product in its new Hybrid Light-Curable (HLC) series ...

2023-06-07 10:45 2648

Samyang Signs Partnership Agreement with Yxintent, China for Dermal Filler Lafullen®

* Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval inChina, with Samyang supplying products worth KRW 100 billion over the next five years * Long-lasting biodegradable dermal filler with natural volume and long-lasting effects, proven safety and efficacy ...

2023-06-07 09:30 4019

Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor

CAMBRIDGE, Mass., June 6, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from "Idea to IND" (I to I™), today announced the appointment of Steve Arkinstall, D.Ph...

2023-06-07 09:00 2584

Translumina bolsters its German presence with acquisition of Lamed GmbH

NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ -- Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further...

2023-06-07 09:00 3268

Sunway Medical Centre is Malaysia's leading hospital in paediatrics, according to Best Specialized Hospitals Asia Pacific Newsweek rankings

The hospital also ranks highly in the areas of Oncology, Neurology and Cardiology SUBANG JAYA, Malaysia, June 7, 2023 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, ranked the top for paediatrics inMalaysia, in the Be...

2023-06-07 08:30 2846

ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023

SHENZHEN, China, June 6, 2023 /PRNewswire/ -- ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT (intratumoral injection) and MVR-T3011 IV (intravenous injection) in both U.S. andChina with all selected to be published (1 chosen for poster dis...

2023-06-07 08:00 2428

Fosun Pharma Participates in 2023 BIO International Convention to Demonstrate its Global Innovation Capabilities

BOSTON, June 6, 2023 /PRNewswire/ -- From June 5th to 8th (Pacific Standard Time), the 2023 BIO International Convention ("BIO 2023") will be held in Boston, Massachusetts, USA. The BIO International Convention is the world's largest gathering of the biotechnology industry along with industry-lead...

2023-06-06 22:15 3233

Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia

Establishment of an eighth Colorcon film coating facility meets the expanding needs of the pharmaceutical and nutritional sectors inSoutheast Asia HARLEYSVILLE, Pa., June 6, 2023 /PRNewswire/ -- Colorcon, Inc. is proud to formally announce its investment in a new manufacturing plant in Johor Stat...

2023-06-06 20:00 4334

Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa

ABIDJAN, Côte d'Ivoire, June 6, 2023 /PRNewswire/ -- To support stronger healthcare delivery and outcomes inWest Africa, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma or the Company, stock code: 600196.SH; 02196.HK) today announced a deepening partnership with IFC to help the comp...

2023-06-06 19:52 2684

LiveSpo represents Vietnam to announce the world's first spore probiotics in nasal spray form at the BIO International Convention

BOSTON, June 6, 2023 /PRNewswire/ -- LiveSpo is the first representative from Vietnam to participate in the BIO International Convention, an exhibition showcasing breakthrough biotechnology solutions, held inBoston, USA. This demonstrates the remarkable development of the Vietnamese pharmaceutica...

2023-06-06 19:40 2639

Promising 2-year updated data from cadonilimab presented at 2023 ASCO highlighting promising efficacy in PD-L1-negative patients

HONG KONG, June 6, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso") released two-year updated data from a Phase Ib/II clinical study of cadonilimab – a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso – in combination with chemotherapy as first-line therapy for advanced gastr...

2023-06-06 19:04 1986

2023 ASCO | Multi-center Data for Combination Study of GenFleet's GFH018 (TGF-β R1 inhibitor) with Anti-PD-1 Antibody Demonstrates Significant Potential to Enhance Efficacy of Immune Checkpoint Inhibitors among ICI-naïve Patients

SHANGHAI and CHICAGO, June 6, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today published the latest results from the phase Ib/II study of GFH018 (TGF-β R1 inhibitor) with toripalimab(anti-PD-1 ...

2023-06-06 19:00 2023

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant - Key features of Plant 5 include seamless ...

2023-06-06 19:00 2245

Midea Healthcare Unveils New Solutions for Smart Healthcare Market

FOSHAN, China, June 6, 2023 /PRNewswire/ -- Midea Healthcare, as one of primarily business for Midea Group (000333.SZ), recently held a new product launch event in CMEF 2023 with its five medical industry consortia – Wandong (WDM), KUKA, Midea Biomedical, Swisslog Healthcare, and Midea Building ...

2023-06-06 16:10 3177

Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer

SINGAPORE, June 6, 2023 /PRNewswire/ -- Jun. 1st, 2023, Biosyngen Pte. Ltd. (hereinafter as "Biosyngen") announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has granted to its application, for immune cell therapy BRG01for the treatment of nas...

2023-06-06 12:58 2763

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that for the second consecutive year, it has release...

2023-06-06 12:20 3259

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phas...

2023-06-06 10:45 2222
1 ... 186187188189190191192 ... 614